A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601)

被引:43
作者
Capdevila, J. [1 ]
Teule, A. [2 ]
Lopez, C. [3 ]
Garcia-Carbonero, R. [4 ]
Benavent, M. [5 ]
Custodio, A. [6 ]
Cubillo, A. [7 ]
Alonso, V. [8 ]
Alonso Gordoa, T. [9 ]
Carmona-Bayonas, A. [10 ]
Crespo, G. [11 ]
Blanco-Codesido, M. [12 ]
Jimenez-Fonseca, P. [13 ]
Viudez, A. [14 ]
La Casta Munoa, A. [15 ]
Sevilla, I. [16 ]
Llanos, M. [17 ]
Segura, A. [18 ]
Hernando-Cubero, J. [1 ]
Manzano, J. L. [19 ]
机构
[1] Vall Hebron Inst Oncol VHIO, Vall Hebron Univ Hosp, Med Oncol Dept, Barcelona, Spain
[2] Inst Catala Oncol ICO IDIBELL, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[3] Hosp Univ Marques Valdecilla, Med Oncol, Santander, Spain
[4] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
[5] Inst Biomed Sevilla IBIS, Hosp Virgen del Rocio, Med Oncol, Seville, Spain
[6] Hosp Univ La Paz, Med Oncol Dept, Madrid, Spain
[7] Hosp Univ HM Sanchinarro, Ctr Integral Oncol Clara Campal HM CIOCC, Madrid, Spain
[8] Hosp Univ Miguel Servet, Inst Aragones Invest Sanitaria, Zaragoza, Spain
[9] Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain
[10] Hosp Univ Morales Meseguer, Serv Hematol & Oncol Med, Murcia, Spain
[11] Hosp Univ Burgos, Med Oncol, Burgos, Spain
[12] Hosp Gen Univ Gregorio Maranon, Dept Oncol, Madrid, Spain
[13] Hosp Univ Cent Asturias, Med Oncol, Oviedo, Spain
[14] Complejo Hosp Navarra, Dept Oncol, Pamplona, Spain
[15] Hosp Univ Donostia, Serv Oncol Med, Donostia San Sebastian, Spain
[16] Hosp Univ Virgen de la Victoria, Serv Oncol, Malaga, Spain
[17] Hosp Univ Canarias, Med Oncol, San Cristobal Laguna, Spain
[18] Hosp Univ & Politecn La Fe, Serv Oncol Med, Valencia, Spain
[19] Hosp Badalona Germans Trias & Pujol, Med Oncol, Badalona, Spain
关键词
D O I
10.1016/j.annonc.2020.08.1373
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1157O
引用
收藏
页码:S770 / S771
页数:2
相关论文
empty
未找到相关数据